Remove male condoms from the women's preventive services mandate

What has happened

1. Jan 5, 2026 Not started

   Male condoms have not been removed from the HRSA-supported Women's Preventive Services Guidelines. The single in-window update to the Guidelines is the cervical cancer screening recommendation accepted on 2026-01-05; the contraception guideline, which is where the male-method question sits, was neither proposed for change nor changed. No Departments' rule or FAQ narrows the contraceptive coverage requirement to exclusively female methods. HRSA's own Guidelines page was read on 2026-09-03 and answers this in terms: item **(14) condoms** remains in the enumerated full range of FDA-approved contraceptives that must be covered without cost sharing. The page's own stamp is "Date Last Reviewed: December 2025"; the guideline update it reviewed is the cervical-cancer-screening change, and the contraceptive list was left alone. This is the moved-the-other-way case: a dated in-window Primary document on the ask's exact object, showing the object unchanged. **Dating note:** the HRSA page gives a month only (December 2025), so the event and the citation take the Federal Register date of the guideline update itself, 2026-01-05.

   • HRSA notice: Update to the Women's Preventive Services Guidelines (accepts the WPSI cervical-cancer-screening recommendation after public comment; records that HRSA has funded WPSI cooperative agreements since 2016 and that publishing a Federal Register notice for comment is standard practice)

     Primary Executive branch Jan 5, 2026

   • HRSA-supported Women's Preventive Services Guidelines — the enumerated contraceptive full range, item (14) condoms and item (17) emergency contraception (ulipristal acetate), and fertility awareness–based methods as instruction only and 'less effective' (Date Last Reviewed: December 2025)

     Primary Executive branch Jan 5, 2026